• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过氧化物酶体增殖物激活受体α激动剂非诺贝特可减轻精神分裂症神经发育模型中的前脉冲抑制破坏。

The PPARα Agonist Fenofibrate Reduces Prepulse Inhibition Disruption in a Neurodevelopmental Model of Schizophrenia.

作者信息

Rolland Benjamin, Marche Kevin, Cottencin Olivier, Bordet Régis

机构信息

Département de Pharmacologie Médicale, EA 1046, Université Lille Nord de France, 1 place de Verdun, 59000 Lille, France.

出版信息

Schizophr Res Treatment. 2012;2012:839853. doi: 10.1155/2012/839853. Epub 2012 May 15.

DOI:10.1155/2012/839853
PMID:22966448
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3420697/
Abstract

Oxidative stress has been implicated in neurodevelopmental theories of schizophrenia. Antioxidant Peroxysome Proliferator-Activated Receptors α (PPARα) agonist fenofibrate has neuroprotective properties and could reverse early preclinical infringements that could trigger the illness. We have evaluated the neuroprotective interest of fenofibrate in a neurodevelopmental rat model of schizophrenia. The oxidative lesion induced by Kainic Acid (KA) injection at postnatal day (PND) 7 has previously been reported to disrupt Prepulse Inhibition (PPI) at PND56 but not at PND35. In 4 groups of 15 male rats each, KN (KA-PND7 + normal postweaning food), KF (KA-PND7 + fenofibrate 0.2% food), ON (saline-PND7 + normal food), and OF (saline + fenofibrate food), PPI was recorded at PND35 and PND56. Three levels of prepulse were used: 73 dB, 76 dB, and 82 dB for a pulse at 120 dB. Four PPI scores were analyzed: PPI73, PPI76, PPI82, and mean PPI (PPIm). Two-way ANOVAs were used to evaluate the effects of both factors (KA + fenofibrate), and, in case of significant results, intergroup Student's t-tests were performed. We notably found a significant difference (P < 0.05) in PPIm between groups KN and KF at PND56, which supposes that fenofibrate could be worthy of interest for early neuroprotection in schizophrenia.

摘要

氧化应激与精神分裂症的神经发育理论有关。抗氧化剂过氧化物酶体增殖物激活受体α(PPARα)激动剂非诺贝特具有神经保护特性,可逆转可能引发该疾病的早期临床前损害。我们评估了非诺贝特在精神分裂症神经发育大鼠模型中的神经保护作用。先前有报道称,在出生后第7天(PND7)注射 kainic 酸(KA)所诱导的氧化损伤会破坏PND56时的前脉冲抑制(PPI),但不会破坏PND35时的PPI。在4组每组15只雄性大鼠中,KN组(PND7注射KA + 正常断奶后食物)、KF组(PND7注射KA + 0.2%非诺贝特食物)、ON组(PND7注射生理盐水 + 正常食物)和OF组(生理盐水 + 非诺贝特食物),在PND35和PND56记录PPI。使用了三个前脉冲水平:120dB的脉冲对应73dB、76dB和82dB。分析了四个PPI分数:PPI73、PPI76、PPI82和平均PPI(PPIm)。使用双向方差分析来评估两个因素(KA + 非诺贝特)的影响,若结果显著,则进行组间学生t检验。我们特别发现,在PND56时,KN组和KF组之间的PPIm存在显著差异(P < 0.05),这表明非诺贝特可能对精神分裂症的早期神经保护具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ae5/3420697/68d6e448735e/SPRT2012-839853.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ae5/3420697/68d6e448735e/SPRT2012-839853.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ae5/3420697/68d6e448735e/SPRT2012-839853.001.jpg

相似文献

1
The PPARα Agonist Fenofibrate Reduces Prepulse Inhibition Disruption in a Neurodevelopmental Model of Schizophrenia.过氧化物酶体增殖物激活受体α激动剂非诺贝特可减轻精神分裂症神经发育模型中的前脉冲抑制破坏。
Schizophr Res Treatment. 2012;2012:839853. doi: 10.1155/2012/839853. Epub 2012 May 15.
2
The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia.过氧化物酶体增殖物激活受体α激动剂非诺贝特可减轻精神分裂症母源免疫激活大鼠模型中多巴胺功能障碍。
CNS Neurosci Ther. 2019 May;25(5):549-561. doi: 10.1111/cns.13087. Epub 2018 Nov 21.
3
Delayed onset of prepulse inhibition deficits following kainic acid treatment on postnatal day 7 in rats.出生后第7天给予大鼠海藻酸处理后,前脉冲抑制缺陷延迟出现。
Eur J Neurosci. 2004 Nov;20(10):2639-48. doi: 10.1111/j.1460-9568.2004.03731.x.
4
Altered prepulse inhibition in rats treated prenatally with the antimitotic Ara-C: an animal model for sensorimotor gating deficits in schizophrenia.产前用抗有丝分裂药物阿糖胞苷处理的大鼠的前脉冲抑制改变:一种精神分裂症感觉运动门控缺陷的动物模型。
Psychopharmacology (Berl). 2004 Jul;174(2):177-89. doi: 10.1007/s00213-003-1757-7.
5
High-fat diet-induced renal cell apoptosis and oxidative stress in spontaneously hypertensive rat are ameliorated by fenofibrate through the PPARα-FoxO3a-PGC-1α pathway.非诺贝特通过PPARα-FoxO3a-PGC-1α途径改善高脂饮食诱导的自发性高血压大鼠肾细胞凋亡和氧化应激。
Nephrol Dial Transplant. 2012 Jun;27(6):2213-25. doi: 10.1093/ndt/gfr613. Epub 2011 Nov 9.
6
The effect of peroxisome proliferator-activated receptors alpha (PPARalpha) agonist, fenofibrate, on lipid peroxidation, total antioxidant capacity, and plasma paraoxonase 1 (PON 1) activity.过氧化物酶体增殖物激活受体α(PPARα)激动剂非诺贝特对脂质过氧化、总抗氧化能力及血浆对氧磷酶1(PON 1)活性的影响。
J Physiol Pharmacol. 2002 Sep;53(3):463-75.
7
Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, exerts neuroprotective effects in traumatic brain injury.非诺贝特,一种过氧化物酶体增殖物激活受体α激动剂,在创伤性脑损伤中发挥神经保护作用。
Neurosci Lett. 2005 Nov 4;388(1):7-12. doi: 10.1016/j.neulet.2005.06.019.
8
Neonatal NMDA receptor antagonist treatments have no effects on prepulse inhibition of postnatal day 25 Sprague-Dawley rats.新生期NMDA受体拮抗剂治疗对出生后25天的Sprague-Dawley大鼠的前脉冲抑制没有影响。
Neurotoxicology. 2009 Jan;30(1):151-4. doi: 10.1016/j.neuro.2008.10.011. Epub 2008 Nov 7.
9
Does genetic BDNF deficiency in rats interact with neurotransmitter control of prepulse inhibition? Implications for schizophrenia.大鼠基因脑源性神经营养因子缺乏是否与前脉冲抑制的神经递质控制相互作用?对精神分裂症的影响。
Prog Neuropsychopharmacol Biol Psychiatry. 2017 Apr 3;75:192-198. doi: 10.1016/j.pnpbp.2017.02.009. Epub 2017 Feb 10.
10
Fenofibrate A peroxisome proliferator activated receptor-α agonist treatment ameliorates Concanavalin A-induced hepatitis in rats.非诺贝特(一种过氧化物酶体增殖物激活受体-α激动剂)治疗可改善伴刀豆球蛋白 A 诱导的大鼠肝炎。
Eur J Pharmacol. 2013 Dec 5;721(1-3):35-42. doi: 10.1016/j.ejphar.2013.09.058. Epub 2013 Oct 17.

引用本文的文献

1
Current View on PPAR-α and Its Relation to Neurosteroids in Alzheimer's Disease and Other Neuropsychiatric Disorders: Promising Targets in a Therapeutic Strategy.当前对 PPAR-α 的认识及其与阿尔茨海默病和其他神经精神疾病中神经甾体的关系:治疗策略中的有前途靶点。
Int J Mol Sci. 2024 Jun 28;25(13):7106. doi: 10.3390/ijms25137106.
2
PPARα Signaling: A Candidate Target in Psychiatric Disorder Management.过氧化物酶体增殖物激活受体α 信号通路:精神障碍管理的候选靶点
Biomolecules. 2022 May 20;12(5):723. doi: 10.3390/biom12050723.
3
Repurposing Peroxisome Proliferator-Activated Receptor Agonists in Neurological and Psychiatric Disorders.

本文引用的文献

1
Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: possible neuroprotective mechanisms.过氧化物酶体增殖物激活受体-α激活可减轻 3-硝基丙酸诱导的大鼠行为和生化改变:可能的神经保护机制。
Eur J Pharmacol. 2012 Jan 5;674(1):33-43. doi: 10.1016/j.ejphar.2011.10.029. Epub 2011 Oct 26.
2
N-acetylcysteine normalizes neurochemical changes in the glutathione-deficient schizophrenia mouse model during development.N-乙酰半胱氨酸可使发育过程中谷胱甘肽缺乏型精神分裂症小鼠模型的神经化学变化恢复正常。
Biol Psychiatry. 2012 Jun 1;71(11):1006-14. doi: 10.1016/j.biopsych.2011.07.035. Epub 2011 Sep 25.
3
在神经和精神疾病中重新利用过氧化物酶体增殖物激活受体激动剂。
Pharmaceuticals (Basel). 2021 Oct 8;14(10):1025. doi: 10.3390/ph14101025.
4
Reversing the Psychiatric Effects of Neurodevelopmental Cannabinoid Exposure: Exploring Pharmacotherapeutic Interventions for Symptom Improvement.逆转神经发育性大麻素暴露的精神效应:探索改善症状的药物治疗干预措施。
Int J Mol Sci. 2021 Jul 23;22(15):7861. doi: 10.3390/ijms22157861.
5
Peroxisome Proliferator Activated Receptor Agonists Modulate Transposable Element Expression in Brain and Liver.过氧化物酶体增殖物激活受体激动剂调节大脑和肝脏中转座元件的表达。
Front Mol Neurosci. 2018 Sep 19;11:331. doi: 10.3389/fnmol.2018.00331. eCollection 2018.
6
Activation of Sterol Regulatory Element Binding Factors by Fenofibrate and Gemfibrozil Stimulates Myelination in Zebrafish.非诺贝特和吉非贝齐对固醇调节元件结合因子的激活作用可促进斑马鱼的髓鞘形成。
Front Pharmacol. 2016 Jul 11;7:206. doi: 10.3389/fphar.2016.00206. eCollection 2016.
7
In search for novel strategies towards neuroprotection and neuroregeneration: is PPARα a promising therapeutic target?寻找神经保护和神经再生的新策略:过氧化物酶体增殖物激活受体α是一个有前景的治疗靶点吗?
Neural Regen Res. 2015 Sep;10(9):1409-12. doi: 10.4103/1673-5374.165313.
8
Evidence of Mitochondrial Dysfunction within the Complex Genetic Etiology of Schizophrenia.精神分裂症复杂遗传病因中存在线粒体功能障碍的证据。
Mol Neuropsychiatry. 2015 Dec;1(4):201-19. doi: 10.1159/000441252. Epub 2015 Oct 28.
9
Abnormal behaviors and developmental disorder of hippocampus in zinc finger protein 521 (ZFP521) mutant mice.锌指蛋白521(ZFP521)突变小鼠的异常行为及海马体发育障碍
PLoS One. 2014 Mar 27;9(3):e92848. doi: 10.1371/journal.pone.0092848. eCollection 2014.
10
PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors.过氧化物酶体增殖物激活受体 α 通过一种涉及α7 型烟碱型乙酰胆碱受体的新机制调节中脑多巴胺神经元的胆碱能驱动活性。
J Neurosci. 2013 Apr 3;33(14):6203-11. doi: 10.1523/JNEUROSCI.4647-12.2013.
Transition to adulthood: the critical period for pre-emptive, disease-modifying care for schizophrenia and related disorders.
向成年期过渡:精神分裂症及相关障碍采取先发制人、改变疾病进程的治疗的关键时期。
Schizophr Bull. 2011 May;37(3):524-30. doi: 10.1093/schbul/sbr027.
4
Schizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse.精神分裂症,“事实为准”6. 推进精神分裂症概念:从大象到老鼠。
Schizophr Res. 2011 Apr;127(1-3):3-13. doi: 10.1016/j.schres.2011.01.011. Epub 2011 Feb 12.
5
Models of neurodevelopmental abnormalities in schizophrenia.精神分裂症的神经发育异常模型。
Curr Top Behav Neurosci. 2010;4:435-81. doi: 10.1007/7854_2010_57.
6
Prepulse inhibition of the startle reflex: a window on the brain in schizophrenia.惊跳反射的前脉冲抑制:精神分裂症大脑的一扇窗口。
Curr Top Behav Neurosci. 2010;4:349-71. doi: 10.1007/7854_2010_61.
7
Fenofibrate treatment enhances antioxidant status and attenuates endothelial dysfunction in streptozotocin-induced diabetic rats.非诺贝特治疗可增强链脲佐菌素诱导的糖尿病大鼠的抗氧化状态并减轻内皮功能障碍。
Exp Diabetes Res. 2010;2010:828531. doi: 10.1155/2010/828531. Epub 2010 Dec 27.
8
Fetal alcohol-induced hyperactivity is reversed by treatment with the PPARα agonist fenofibrate in a rat model.胎儿酒精诱导的多动可通过 PPARα 激动剂非诺贝特在大鼠模型中的治疗得到逆转。
Psychopharmacology (Berl). 2011 Mar;214(1):285-96. doi: 10.1007/s00213-010-1960-2. Epub 2010 Jul 27.
9
Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors.过氧化物酶体增殖物激活受体-α通过烟碱型乙酰胆碱受体调节多巴胺能神经元的活性。
Biol Psychiatry. 2010 Aug 1;68(3):256-64. doi: 10.1016/j.biopsych.2010.04.016. Epub 2010 Jun 8.
10
PPARalpha: energy combustion, hypolipidemia, inflammation and cancer.过氧化物酶体增殖物激活受体α:能量燃烧、降血脂、炎症与癌症。
Nucl Recept Signal. 2010 Apr 16;8:e002. doi: 10.1621/nrs.08002.